Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Should You Buy Regeneron Pharmaceuticals Stock Before Oct. 30?

The healthcare company will release its third-quarter results next month.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Monday 28 September →